JP Morgan Private Wealth Advisors’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10,581
Closed -$223K 1745
2023
Q2
$223K Sell
10,581
-1,411
-12% -$26.8K ﹤0.01% 1356
2023
Q1
$204K Buy
+11,992
New +$233K ﹤0.01% 1823
2022
Q1
Sell
-8,583
Closed -$234K 2041
2021
Q4
$234K Buy
8,583
+832
+11% +$23.8K ﹤0.01% 1851
2021
Q3
$213K Buy
7,751
+142
+2% +$3.73K ﹤0.01% 1833
2021
Q2
$217K Buy
7,609
+651
+9% +$19.3K ﹤0.01% 1808
2021
Q1
$237K Sell
6,958
-304
-4% -$11.6K ﹤0.01% 1620
2020
Q4
$242K Sell
7,262
-938
-11% -$34.3K ﹤0.01% 1578
2020
Q3
$264K Sell
8,200
-1,057
-11% -$30.4K ﹤0.01% 1413
2020
Q2
$255K Buy
+9,257
New +$219K ﹤0.01% 1375

Other funds holding INSM

JP Morgan Private Wealth Advisors's INSM Position: Q3 2023 in Review

JP Morgan Private Wealth Advisors sold out of Insmed (INSM) in Q3 2023, closing a stake of 10,581 shares — an estimated $223K sold.

JP Morgan Private Wealth Advisors first reported a position in INSM in Q2 2020 and held it in 9 quarters. The position peaked at $264K in Q3 2020. 252 funds tracked by Wall St. Rank hold INSM as of Q3 2023.

  • JP Morgan Private Wealth Advisors reported no remaining Insmed position as of Q3 2023 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 10,581 Insmed shares in Q3 2023, an estimated $223K.
  • JP Morgan Private Wealth Advisors first reported a position in Insmed in Q2 2020 and held it in 9 quarters.
  • JP Morgan Private Wealth Advisors's Insmed position peaked at $264K in Q3 2020.
  • 252 funds tracked by Wall St. Rank held Insmed as of Q3 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.